Cerence (CRNC) Cash & Equivalents (2019 - 2026)

Cerence has reported Cash & Equivalents for 8 years, with the latest figure at $108.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 7.76% year-over-year to $108.3 million; the trailing twelve-month figure through Mar 2026 stood at $108.3 million (down 7.76% YoY), and the FY2025 full-year result was $84.0 million, down 30.84% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $108.3 million, up from $92.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $121.5 million in Q3 2024, with the low at $17.7 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $94.8 million across 5 years, with a median of $98.7 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 85.34% — and 2023, when it surged 385.97%.
• Cerence's Cash & Equivalents stood at $90.7 million in 2022, then climbed by 8.91% to $98.7 million in 2023, then advanced by 5.44% to $104.1 million in 2024, then decreased by 11.5% to $92.1 million in 2025, then gained by 17.51% to $108.3 million in 2026.
• The last three Cash & Equivalents figures came in at $108.3 million (Q1 2026), $92.1 million (Q4 2025), and $84.0 million (Q3 2025), per Business Quant data.